Blue Shield of California has released an updated medical policy that includes coverage for the use of Agendia's MammaPrint 70-gene signature breast cancer recurrence risk test in women diagnosed with primary invasive breast cancer.
Blue Shield of Calif. now covers Agendia's MammaPrint test
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.